{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:22:52Z","timestamp":1794576172978,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014423","name":"Environmental Restoration and Conservation Agency","doi-asserted-by":"publisher","award":["5-1455"],"award-info":[{"award-number":["5-1455"]}],"id":[{"id":"10.13039\/100014423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.curtheres.2026.100845","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:43:23Z","timestamp":1789602203000},"page":"100845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence and correlates of antinuclear antibodies in a Japanese community sample: a cross-sectional study"],"prefix":"10.1016","volume":"105","author":[{"given":"Tamanna","family":"Tabassum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-8788","authenticated-orcid":false,"given":"Tatsuyoshi","family":"Ikenoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-2267","authenticated-orcid":false,"given":"Takuji","family":"Hinoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2026.100845_bib0001","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.autrev.2015.01.017","article-title":"Autoantibodies 2015: from diagnostic biomarkers toward prediction, prognosis and prevention","volume":"14","author":"Damoiseaux","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.curtheres.2026.100845_bib0002","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"American college of rheumatology Ad Hoc committee on immunologic testing G: evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.curtheres.2026.100845_bib0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41927-023-00349-4","article-title":"Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease","volume":"7","author":"Zanussi","year":"2023","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-4-1","article-title":"Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited","volume":"4","author":"Kumar","year":"2009","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0005","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/labmed\/lmy024","article-title":"Antinuclear antibodies: marker of diagnosis and evolution in autoimmune diseases","volume":"49","author":"Sur","year":"2018","journal-title":"Lab Med"},{"key":"10.1016\/j.curtheres.2026.100845_bib0006","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2141.2003.04587.x","article-title":"Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma","volume":"123","author":"Guyomard","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0007","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events","volume":"36","author":"Liang","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0008","first-page":"305","article-title":"Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: acute versus chronic patients","volume":"10","author":"Sedaghat","year":"2014","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.curtheres.2026.100845_bib0009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0010","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.curtheres.2026.100845_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-017-1338-5","article-title":"Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study","volume":"19","author":"Akmatov","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.curtheres.2026.100845_bib0012","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.020502","article-title":"Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine","volume":"31","author":"Tesija Kuna","year":"2021","journal-title":"Biochem Med"},{"key":"10.1016\/j.curtheres.2026.100845_bib0013","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00004836-200111000-00012","article-title":"Expression and clinical significance of antinuclear antibody in hepatitis C virus infection","volume":"33","author":"Peng","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.curtheres.2014.06.004","article-title":"The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study","volume":"76","author":"Guo","year":"2014","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.curtheres.2026.100845_bib0015","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1002\/art.38867","article-title":"Association between antinuclear antibodies and the HLA class II locus and heterogeneous characteristics of staining patterns: the Nagahama study","volume":"66","author":"Terao","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0016","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.autrev.2015.10.007","article-title":"Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years","volume":"15","author":"Selmi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.curtheres.2026.100845_bib0017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/acb.2009.049","article-title":"Detection and identification of antinuclear antibodies (ANA) in a large community hospital","volume":"64","author":"Verstegen","year":"2009","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.curtheres.2026.100845_bib0018","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \"healthy\" individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.curtheres.2026.100845_bib0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","volume":"27","author":"Wandstrat","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.curtheres.2026.100845_bib0020","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar3271","article-title":"Risk factors for ANA positivity in healthy persons","volume":"13","author":"Li","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.curtheres.2026.100845_bib0021","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00296-016-3533-0","article-title":"Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008-2015: a cross-sectional study involving 10,814 subjects","volume":"36","author":"Racoubian","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.curtheres.2026.100845_bib0022","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1196\/annals.1313.120","article-title":"Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural\/predictive autoantibodies","volume":"1050","author":"Shovman","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.curtheres.2026.100845_bib0023","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1440-1711.2003.01181.x","article-title":"Antinuclear antibody testing in a regional immunopathology laboratory","volume":"81","author":"Roberts-Thomson","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.30084","article-title":"Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases","volume":"63","author":"Mariz","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.curtheres.2026.100845_bib0025","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s00296-011-2134-1","article-title":"Antinuclear antibody positive autoimmune disorders in North India: an appraisal","volume":"32","author":"Minz","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.curtheres.2026.100845_bib0026","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.20096","article-title":"Anti-DFS70 antibodies in 597 healthy hospital workers","volume":"50","author":"Watanabe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.curtheres.2026.100845_bib0027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10157-008-0030-0","article-title":"Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study","volume":"12","author":"Ishikawa","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2022.114094","article-title":"Association between antinuclear antibody positivity and chemical exposure among pregnant Japanese women: a cross-sectional study based on the Japan environment and Children's study","volume":"248","author":"Fukushige","year":"2023","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.curtheres.2026.100845_bib0029","first-page":"22","article-title":"Escape from X chromosome inactivation and the female predominance in autoimmune diseases","author":"Youness","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.curtheres.2026.100845_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13293-020-00325-4","article-title":"Mechanisms of sex hormones in autoimmunity: focus on EAE","volume":"11","author":"Lasrado","year":"2020","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.curtheres.2026.100845_bib0031","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/ar2825","article-title":"Why are women predisposed to autoimmune rheumatic diseases?","volume":"11","author":"Oliver","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.curtheres.2026.100845_bib0032","doi-asserted-by":"crossref","first-page":"J135","DOI":"10.1016\/j.jaut.2011.11.001","article-title":"Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus","volume":"38","author":"Strickland","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.curtheres.2026.100845_bib0033","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1007\/s10067-025-07638-y","article-title":"Antinuclear antibodies as a risk factor for ischemic stroke or death in elderly patients with atrial fibrillation despite anticoagulation","volume":"44","author":"Hanarz","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0034","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00296-021-05033-9","article-title":"Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study","volume":"42","author":"Krzemien","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.curtheres.2026.100845_bib0035","first-page":"1203","article-title":"Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis?","volume":"34","author":"Liang","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0036","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1741-7015-11-94","article-title":"Age-related autoimmunity","volume":"11","author":"Vadasz","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.curtheres.2026.100845_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110906","article-title":"Sex differences in the association between antinuclear antibody positivity with diabetes and multimorbidity in older adults: results from the Baltimore Longitudinal Study of Aging","volume":"135","author":"Meier","year":"2020","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0038","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2008.096487","article-title":"Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies","volume":"69","author":"Sugiyama","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.curtheres.2026.100845_bib0039","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar750","article-title":"Smoking-gender interaction and risk for rheumatoid arthritis","volume":"5","author":"Krishnan","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.curtheres.2026.100845_bib0040","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.curtheres.2026.100845_bib0041","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0165-5728(97)00231-2","article-title":"Immunomodulatory effects of cigarette smoke","volume":"83","author":"Sopori","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0042","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Alfredsson L: Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"Klareskog","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0043","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.autrev.2008.04.013","article-title":"Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?","volume":"7","author":"Griffiths","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.curtheres.2026.100845_bib0044","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.2005.039438","article-title":"Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus","volume":"65","author":"Freemer","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.curtheres.2026.100845_bib0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/0961203314520838","article-title":"Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls","volume":"23","author":"Young","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.curtheres.2026.100845_bib0046","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s10067-015-3008-9","article-title":"Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis","volume":"34","author":"Jiang","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.curtheres.2026.100845_bib0047","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.curtheres.2026.100845_bib0048","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Rantap\u00e4\u00e4-Dahlqvist S: Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X26000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X26000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:23:00Z","timestamp":1794572580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X26000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S0011393X26000263"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2026.100845","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and correlates of antinuclear antibodies in a Japanese community sample: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2026.100845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100845"}}